Related Experiment Video
Updated: Jul 31, 2026
08:01
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Summary
Newborns are unnecessarily treated for hypoglycemia due to inaccurate testing and inconsistent care practices. Research findings are often ignored, impacting infant health and breastfeeding.
Area of Science:
- Neonatal care
- Pediatric endocrinology
- Public health
Background:
- Neonatal hypoglycemia is a common concern, requiring accurate diagnosis and appropriate management.
- Variations in clinical practices and adherence to evidence-based guidelines can affect infant outcomes.
- Maternal breastfeeding support is crucial for infant nutrition and development.
Purpose of the Study:
- To evaluate the current practices in diagnosing and managing neonatal hypoglycemia.
- To identify the reasons for the gap between research evidence and clinical application.
- To assess the impact of differing hospital protocols on infant care and maternal breastfeeding.
Main Methods:
- Review of current diagnostic tools and treatment protocols for neonatal hypoglycemia.
- Analysis of adherence to established research findings in neonatal units.
- Survey of healthcare professionals' confidence and practices regarding breastfeeding support.
Main Results:
- Inaccurate blood glucose testing strips are frequently used, leading to unnecessary treatments.
- Significant discrepancies exist in care protocols across different hospitals.
- Conflicting advice and lack of confidence in breastfeeding among some professionals hinder lactation establishment.
Conclusions:
- There is a critical need to improve the accuracy of diagnostic tools and standardize care for neonatal hypoglycemia.
- Enhanced implementation of research evidence is essential for optimal infant care.
- Strengthening breastfeeding support requires addressing professional confidence and providing consistent advice to mothers.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...